Variables | Frequency (n; %) |
---|---|
Did they start steroid treatment? | |
Yes | 42 (96.0) |
No | 2 (4.0) |
Did they start treatment with other drugs? | |
Verapamil | 11 (25.0) |
Lithium | 4 (9.0) |
Verapamil plus lithium | 3 (7.0) |
Galcanezumab | 44 (100.0) |
Prescribed dose of galcanezumab | |
240 mg | 8 (18.0) |
300 mg | 29 (66.0) |
360 mg | 7 (16.0) |
Number of times that used galcanezumab | |
Once | 24 (54.5) |
Twice | 9 (20.5) |
≥ Three times | 4 (9.1) |
Lost to follow-up | 7 (15.9) |
Reduction of attacks ≥ 50% after 3 weeks | |
Yes | 29 (66.0) |
No | 8 (18.0) |
Lost to follow-up | 7 (16.0) |